Use of Epigenetic Cell Counting to Determine the Effect of Ozanimod on Circulating Leukocyte Subtypes in Patients With Relapsing Multiple Sclerosis Carlos Bonilla2021-12-06T11:29:50-05:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2021-11-29T17:36:51-05:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-associated Mechanisms of Action Carlos Bonilla2021-11-29T17:35:58-05:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2021-12-06T11:27:52-05:00Resources| Read More
Correlative Analysis of Epigenetic-Based Quantitative PCR Assisted Immune Cells Counting in SUNRISE Trial Subgroup Carlos Bonilla2021-11-29T17:35:07-05:00Resources| Read More
Cytokine Effects of Apremilast as a Mechanism of Efficacy in Systemic-Naive Patients With Moderate Plaque Psoriasis: Results From the UNVEIL Trial Carlos Bonilla2021-11-29T17:34:02-05:00Resources| Read More
Selective Induction of Activated Regulatory T-Cells in Healthy Volunteers by NKTR-358, a Novel IL-2 Conjugate Treg Stimulator, in Development for the Treatment of Autoimmune Diseases Carlos Bonilla2021-11-29T17:37:52-05:00Resources| Read More
Evidence of Target Engagement and Modulation: Biomarker Analysis of the Phase 1b Inhaled Seralutinib Study Carlos Bonilla2021-11-29T17:41:13-05:00Resources| Read More
Novel Approaches To Study FVIII Inhibitor Development in Infant Patient: Hemophilia Inhibitor Pup Study Carlos Bonilla2021-12-06T11:36:09-05:00Resources| Read More
